Andres Forero‐Torres
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment 90
- Oncology top 0.2%
- CAR-T cell therapy research 35
- HER2/EGFR in Cancer Research 34
- Cancer Treatment and Pharmacology 19
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 43
- Immunology top 1%
- Dermatology top 0.5%
-
- Monoclonal and Polyclonal Antibodies Research 31
-
- Advanced Breast Cancer Therapies 22
-
- Breast Cancer Treatment Studies 14
- Co-authors
- Nancy L. BartlettDana A. KennedyAnas YounesEric L. SieversJohn P. LeonardCarmel M. LynchJoseph D. RosenblattRanjana H. Advani
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (45 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Andres Forero‐Torres
159 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Pathology and Forensic Medicine 3.5k
- Oncology 5.1k
- Genetics 1.4k
- Immunology 1.6k
- Dermatology 619
Countries citing papers authored by Andres Forero‐Torres
This map shows the geographic impact of Andres Forero‐Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andres Forero‐Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andres Forero‐Torres more than expected).
Fields of papers citing papers by Andres Forero‐Torres
This network shows the impact of papers produced by Andres Forero‐Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andres Forero‐Torres. The network helps show where Andres Forero‐Torres may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andres Forero‐Torres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2021 | 7 | |
| 3 | 2020 | 107 | |
| 4 | 2020 | 144 | |
| 5 | 2019 | 30 | |
| 6 | 2019 | 28 | |
| 7 | 2017 | 158 | |
| 8 | 2017 | 11 | |
| 9 | 2017 | 3 | |
| 10 | 2015 | 95 | |
| 11 | 2015 | 43 | |
| 12 | 2015 | 75 | |
| 13 | 2015 | 12 | |
| 14 | 2014 | 72 | |
| 15 | 2012 | 54 | |
| 16 | 2012 | 34 | |
| 17 | 2012 | 55 | |
| 18 | Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphomabreakdown → | 2012 | 1014 |
| 19 | 2011 | 160 | |
| 20 | 2004 | 15 |
About Andres Forero‐Torres
Andres Forero‐Torres is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 162 papers that have together received 7.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (90 papers), Chronic Lymphocytic Leukemia Research (43 papers), CAR-T cell therapy research (35 papers), HER2/EGFR in Cancer Research (34 papers), Monoclonal and Polyclonal Antibodies Research (31 papers), Advanced Breast Cancer Therapies (22 papers), Cancer Treatment and Pharmacology (19 papers) and Breast Cancer Treatment Studies (14 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.5k citations), Oncology (5.1k citations) and Genetics (1.4k citations). Andres Forero‐Torres has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Nancy L. Bartlett, Dana A. Kennedy, Anas Younes, Eric L. Sievers, John P. Leonard, Carmel M. Lynch, Joseph D. Rosenblatt, Ranjana H. Advani, Robert Chen and Stephen M. Ansell. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.